The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
Face Blindness & Long COVID: Prosopagnosia Is a New Symptom of Long COVID
30seconds.com
10 April 2023
https://30seconds.com/health/tip/57734/Face-Blindness-Long-COVID-Prosopagnosia-Is-a-New-Symptom-of-Long-COVID
Treating Long-COVID Brain Fog With ME/CFS Guidelines
Medscape
27 March 2023
https://www.medscape.com/viewarticle/989887
Cognitive symptoms, commonly referred to as brain fog, are among the most common persistent or new symptoms after COVID-19. Cognitive symptoms are also often reported by patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
An Update on the Uses of Naltrexone in Clinical Practice
Natural Medicine Journal
01 August 2022
https://www.naturalmedicinejournal.com/journal/an-update-on-the-uses-of-naltrexone-in-clinical-practice
LDN in Clinical Practice - Andrew McCall, MB, ChB, DFM (2021 Conference) (LDN, low dose naltrexone)
The LDN Side Effect Survey Results from 2020 - Jill Brook, MA (2021 Conference) (LDN, low dose naltrexone)
Jill Brook, MA is a Research Advisor to the LDN Research Trust. In this presentation she shares the results of the 2020 LDN Side Effect Survey.
The EMF Toxicity Epidemic - Protection and Treatment - Kent Holtorf, MD (2021 Conference) (LDN, low dose naltrexone)
Longevity - Kent Holtorf, MD (2021 Conference) (LDN, low dose naltrexone)